Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,085 public trials 3,995 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

NCT07256158

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
  • A.O.R.N. G Moscati - U.O.C. Ematologia e Terapie cellulari avanzate Avellino, Italy
  • IRCCS Centro Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy
  • ASST Papa Giovanni XXIII - S.C. Ematologia Bergamo, Italy
View all 38 locations
View Trial Details
Recruiting

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

NCT06003387

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of California, San Diego (UCSD) San Diego, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Hemophilia Center of Western Pennsylvania (HCWP) Pittsburgh, Pennsylvania, United States
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View all 32 locations
View Trial Details
Recruiting

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

NCT07227155

Conditions
Anemia, Anemia, Aplastic, Aplastic Anemias, +8 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Baylor College of Medicine Houston, Texas, United States
View all 14 locations
View Trial Details
Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

NCT04925479

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Indiana UH Riley H for CIU Indianapolis, Indiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Mississippi Medical Center Jackson, Mississippi, United States
  • Columbia University Medical Center New York Presbyterian New York, United States
View all 39 locations
View Trial Details
Recruiting

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

NCT05904106

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Aachen Aachen, Germany
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 18 locations
View Trial Details

Related conditions